China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Why is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. ?

ROCE(HY) Lowest at 13.49%
DEBT-EQUITY RATIO (HY) Highest at -12.02 %
INVENTORY TURNOVER RATIO(HY) Lowest at 2.44%

With ROE of 15.80%, it has a very attractive valuation with a 2.19 Price to Book Value

Over the past year, while the stock has generated a return of -19.56%, its profits have fallen by -9.2%
At the current price, the company has a high dividend yield of 2.1

Below par performance in long term as well as near term

Along with generating -19.56% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

-100.0%

-0.67

31.20%

China Shanghai Composite

15.19%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

16.23%

EBIT Growth (5y)

16.09%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.22

Sales to Capital Employed (avg)

1.06

Tax Ratio

17.88%

Dividend Payout Ratio

50.04%

Pledged Shares

Institutional Holding

ROCE (avg)

21.37%

ROE (avg)

15.25%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.19

EV to EBIT

12.33

EV to EBITDA

9.48

EV to Capital Employed

2.36

EV to Sales

1.57

PEG Ratio

Dividend Yield

2.15%

ROCE (Latest)

19.14%

ROE (Latest)

15.80%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 4,958.14 MM

RAW MATERIAL COST(Y)

Fallen by 0.78% (YoY

CASH AND EQV(HY)

Highest at CNY 20,224.57 MM

NET SALES(Q)

Highest at CNY 7,853.51 MM

-15What is not working for the Company

ROCE(HY)

Lowest at 13.49%

DEBT-EQUITY RATIO (HY)

Highest at -12.02 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.44%

INTEREST(Q)

Highest at CNY 27.89 MM

NET PROFIT(Q)

At CNY 511.48 MM has Fallen at -37.34%

Here's what is working for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 4,958.14 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 7,853.51 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 7,853.51 MM has Grown at 16.87%

over average net sales of the previous four periods of CNY 6,719.63 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Cash and Eqv

Highest at CNY 20,224.57 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by 0.78% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Interest

At CNY 27.89 MM has Grown at 28.66%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest

Highest at CNY 27.89 MM

in the last five periods and Increased by 28.66% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Profit

At CNY 511.48 MM has Fallen at -37.34%

over average net sales of the previous four periods of CNY 816.3 MM

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Debt-Equity Ratio

Highest at -12.02 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 2.44%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio